Beta Drugs Ltd announced plans to acquire 66.09% of Nivian Life Sciences for ₹694 million, strengthening its portfolio and scale in pharmaceuticals. The deal is expected to expand manufacturing capacity, diversify product lines, and enhance market access. Management sees operational synergies and an accelerated growth trajectory following integration.
Show moreStay Ahead – Explore Now! Nifty 50 Dips in Pre-Open While Futures Edge Higher
Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.
Powered By Just Imagine
